Back to Search

Miltenyi Device for Poor Graft Function after Transplant

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Recruiting N/A Interventional Study
Blood And Marrow Transplantation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
200 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for patients who have had a stem cell transplant but are experiencing problems with their graft. If you qualify, you will have the chance to use the Miltenyi device to help improve your treatment outcomes.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have poor or no graft function after my stem cell transplantation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1\) Patients who have poor or no graft function post stem cell transplantation. Exclusion Criteria: N/A
Contacts

Elizabeth Shpall, MD

713-745-2161

eshpall@mdanderson.org

CONTACT

NCT ID: NCT02438904 Source: ClinicalTrials.gov